Aug 11, 2025
Although there are no approved sarcopenia drugs at present, ongoing research is exploring possible pharmacological solutions. Investigational treatments include Selective Androgen Receptor Modulators (SARMs) and myostatin inhibitors, which aim to enhance muscle mass and function. Beyond non-pharmacological approach...
Read More...
Jul 28, 2025
Sarcopenia, often dubbed the “silent muscle thief,” is a progressive loss of skeletal muscle mass and strength that typically begins after the age of 30, accelerating after 60. Affecting up to 50% of adults over 80, sarcopenia isn’t just about frailty—it’s linked to increased risks of falls, fractures, loss of inde...
Read More...
Intratumoral Cancer Therapy: A Potential Weapon To Fight the Battle Against Cancer
Aug 05, 2026
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Newsletter/Whitepaper